Valuation: Illumina, Inc.

Market Cap 33.13B 28.38B 26.55B 24.31B 45.62B 3,170B 46.22B 314B 122B 1,592B 124B 122B 5,267B P/E 2026 *
44.3x
P/E 2027 * 37.5x
Enterprise Value 33.38B 28.59B 26.75B 24.49B 45.95B 3,193B 46.56B 316B 123B 1,604B 125B 123B 5,306B EV / Sales 2026 *
7.22x
EV / Sales 2027 * 6.6x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+2.89%
1 week+14.94%
Current month+6.97%
1 month+13.96%
3 months+51.49%
6 months+86.45%
Current year+67.28%
1 week 187.54
Extreme 187.541
220.43
1 month 186.64
Extreme 186.64
220.43
Current year 112.65
Extreme 112.65
220.43
1 year 88
Extreme 88
220.43
3 years 68.7
Extreme 68.7
220.43
5 years 68.7
Extreme 68.7
492.29
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
18/08/26 Sell

Executive/Senior Manager

-1,033 0.0007%
05/08/26
Corvex Management LP
SellCompany -283,269 0.1872%
05/08/26 Free

Executive/Senior Manager

15,011 0.0099%
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%+14.94%+120.97%+31.06% 33.13B
+0.27%+6.97%+30.08%+18.23% 233B
+1.36%+8.10%+7.33%-12.52% 154B
+1.16%-3.98%-19.38%+32.14% 134B
+2.03%-2.82%-52.12%-0.10% 73B
-0.04%-1.98%+10.63%+17.63% 51.75B
+0.98%+2.26%-15.88%-11.61% 52.24B
+1.73%+7.05%+35.72%+33.77% 44.91B
+1.49%-0.36%+41.41%+53.72% 40.35B
+1.03%+1.53%+2.28%+8.48% 33.8B
Average +1.33%+3.07%+16.10%+17.08% 84.95B
Weighted average by Cap. +1.09%+3.46%+10.37%+14.03%

Financials

2026 *2027 *
Net sales 4.62B 3.96B 3.71B 3.39B 6.37B 442B 6.45B 43.79B 17.08B 222B 17.37B 16.99B 735B 4.91B 4.21B 3.94B 3.6B 6.76B 470B 6.85B 46.5B 18.13B 236B 18.44B 18.04B 781B
Net income 760M 651M 609M 558M 1.05B 72.75B 1.06B 7.2B 2.81B 36.55B 2.85B 2.79B 121B 891M 763M 714M 654M 1.23B 85.27B 1.24B 8.44B 3.29B 42.84B 3.35B 3.27B 142B
Net Debt 246M 211M 197M 181M 339M 23.54B 343M 2.33B 909M 11.82B 924M 904M 39.11B -729M -624M -584M -535M -1B -69.75B -1.02B -6.9B -2.69B -35.04B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
21/08/26 US$219.40 +2.89% 1,917,222
20/08/26 US$213.24 +4.02% 3,284,715
19/08/26 US$205.00 +8.87% 2,090,865
18/08/26 US$188.29 -2.51% 1,192,959
17/08/26 US$193.14 +1.18% 995,956
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
219.40USD
Average target price
198.89USD
Spread / Average Target
-9.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock